To view the fulltext, please log in
To view the pdf, please log in
The pre-operative findings and operative outcome were evaluated from patient records in 136 patients (182 ears) who had surgery for external auditory canal (EAC) exostoses. Furthermore, 114 patients (84%) replied to a questionnaire inquiring about the symptoms and the operation’s impact on their quality of life. The main symptoms prior to the surgery were recurrent external otitis, hearing loss and wax retention. Interestingly, 23 patients (21%) were operated without any symptoms. After the operation, 75 patients (66%) had relief of their symptoms. In 33 patients (29%) the symptoms remained the same, and in 5 patients (4%) they became worse. The quality of life improved in 77 patients (68%); 19 patients (14%) had a complication due to the surgery, and 8 patients (6%) needed a re-operation. The surgery for EAC exostoses should be reserved only for symptomatic cases and only for experienced specialists in order to minimize complications and unnecessary operations.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- Fenton JE, Turner J, Fagan PA: A histopathologic review of temporal bone exostoses and osteomata. Laryngoscope 1996;106:624–628.
- Di Bartolomeo JR: Exostoses of the external auditory canal. Ann Otol Rhinol Laryngol 1979;88(suppl 61):1–20.
- Schucknecht H: Exostoses of external auditory canal; in Schucknecht HF (ed): Pathology of the Ear. Philadelphia, Lea & Febiger, 1993, pp 398–399.
- Wong BJF, Cervantes W, Doyle KJ, Karamzadeh AM, Boys P, Brauel G, Mushtaq E: Prevalence of external auditory canal exostosis in surfers. Arch Otolaryngol Head Neck Surg 1999;1025:969–972.
- Sheehy J: Diffuse exostoses and osteomata of the external auditory canal: A report of 100 operations. Otolaryngol Head Neck Surg 1982;90:337–342.
- Fisher EW, McManus TC: Surgery for external auditory canal exostosis and osteomata. Laryngol Otol 1994;108:106–110.
- Whitaker SR, Cordier A, Kosjakov S, Charbonneau R: Treatment of external auditory canal exostoses. Laryngoscope 1998;108:195–199.
- Graham MD: Osteomas and oxostoses of the external auditory canal: A clinical, histopathological and scanning electron microscopic study. Ann Otol 1979;88:566–572.